Neuronal cell death

M Fricker, AM Tolkovsky, V Borutaite… - Physiological …, 2018 - journals.physiology.org
Neuronal cell death occurs extensively during development and pathology, where it is
especially important because of the limited capacity of adult neurons to proliferate or be …

Therapeutics of Alzheimer's disease: Past, present and future

R Anand, KD Gill, AA Mahdi - Neuropharmacology, 2014 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia worldwide. The etiology is
multifactorial, and pathophysiology of the disease is complex. Data indicate an exponential …

Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles

DL Castillo-Carranza, U Sengupta… - Journal of …, 2014 - Soc Neuroscience
Recent findings suggest that tau oligomers, which form before neurofibrillary tangles (NFTs),
are the true neurotoxic tau entities in neurodegenerative tauopathies, including Alzheimer's …

Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus

G M. Ashraf, N H. Greig, T A. Khan… - CNS & Neurological …, 2014 - benthamdirect.com
In general, proteins can only execute their various biological functions when they are
appropriately folded. Their amino acid sequence encodes the relevant information required …

Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors

HO Tayeb, HD Yang, BH Price, FI Tarazi - Pharmacology & therapeutics, 2012 - Elsevier
Alzheimer's disease (AD) is the most common cause of memory impairment and dementia in
the elderly. AD is pathologically characterized by extracellular deposits of beta-amyloid (Aβ) …

Tau oligomers associate with inflammation in the brain and retina of tauopathy mice and in neurodegenerative diseases

AN Nilson, KC English, JE Gerson… - Journal of …, 2017 - content.iospress.com
It is well-established that inflammation plays an important role in Alzheimer's disease (AD)
and frontotemporal lobar dementia (FTLD). Inflammation and synapse loss occur in disease …

Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross‐seeding behavior

G Ghag, N Bhatt, DV Cantu… - Protein …, 2018 - Wiley Online Library
Several studies have proposed that fibrillary aggregates of tau and other amyloidogenic
proteins are neurotoxic and result in numerous neurodegenerative diseases. However …

Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach

L Troquier, R Caillierez, S Burnouf… - Current Alzheimer …, 2012 - ingentaconnect.com
Recent data indicate that Tau immunotherapy may be relevant for interfering with
neurofibrillary degeneration in Alzheimer disease and related disorders referred to as …

Tau oligomers and fibrils induce activation of microglial cells

I Morales, JM Jiménez, M Mancilla… - Journal of Alzheimer's …, 2013 - content.iospress.com
Neuroinflammation is a process related to the onset of several neurodegenerative disorders,
including Alzheimer's disease (AD). Increasing sets of evidence support the major role of …

Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model

DL Castillo-Carranza, MJ Guerrero-Muñoz… - Journal of …, 2015 - Soc Neuroscience
In Alzheimer's disease (AD), the pathological accumulation of tau appears to be a
downstream effect of amyloid β protein (Aβ). However, the relationship between these two …